Great to see this first approval to commence the Phase III.
An untouched $1B per annum market is at the door step, and another $600M from the US in due time, with our CSO an author of clinical and diagnostic guidelines to help market penetration, MST have peak sales of $396Mpa USD.
$35M MC with $31M cash, for an EV of $4M has to be one of the cheapest active Phase III on the listed market. For what could be $396Mpa peak sales as per MST report.
With $26M raised at $1.33 per share with Andrew Twiggy Forrest pouring in $5M, prices of $0.50c represent comparative value.
Exciting times to watch this one unfold!
Great to see this first approval to commence the Phase III. An...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.237M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 28352 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.7¢ | 8998 | 1 |
View Market Depth
| Last trade - 16.21pm 28/07/2025 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable